Key Competitors - Spatial Omics Industry

 

For instance, the MERSCOPE platform, the exclusive platform for the MERFISH technology, was commercialised by vizgen, a life science business committed to enhancing human health by visualising single cell spatial genomics information, in August 2021. Through combinatorial labelling, sequential imaging, and error-resistant barcoding, MERFISH offers the best detection efficiency currently available for spatially profiling gene expression across whole tissues and resolving individual transcripts with nanometre scale resolution.

The world's first comprehensive sample to insight high plex spatial omics solution for single cell level characterisation was also unveiled by Veranome Biosystems LLC in March 2021. It has been shown that the Pisces technology can map hundreds of custom gene panels in tissues at sub cellular resolution with great sensitivity and gene counts per cell.

The global market for Spatial Omics is anticipated to reach US$ 267 million in 2022 and is projected to grow at a CAGR of 9.4% from 2022 to 2030.

Major Players in the Spatial Omics Industry:

10x Genomics:

1. A life science technology business with headquarters in the US is called 10x Genomics Inc. Its solutions for analysing biological systems include tools, supplies, and software. Created in 2012. Tetramer (Feb 2021), ReadCoor (Oct 2020), and CARTANA (Aug 2020) are the most recent acquisitions.

Akoya Bioscience Inc:

2. Life sciences technology startup Akoya Biosciences Inc. It is providing spatial biology solutions aimed at revolutionising basic and applied research. Created in 2015. Headquarters in Marlborough, Massachusetts, USA. -The Spatial Biology CompanyTM Akoya Biosciences, Inc., reported in 2019 that it has successfully raised $50 million from both new and existing investors.

Biognosys AG:

3. Creator of new proteomics techniques that will revolutionise life science research and enable highly multiplexed protein measurement. created in 2008. Swiss headquarters are in Zurich. On January 3, 2023, Bruker Corporation (NasdaqGS:BRKR) paid CHF 73.5 million to acquire a 97.15% share in Biognosys AG.

Bio-Techne:

4. Bio-Techne, a life sciences company based in Minnesota, provides consumables and equipment to the pharmaceutical, biotechnology, academic, and diagnostic industries. Built in 1976. United States headquarters. In 2022, the global life sciences business Bio-Techne Corporation (NASDAQ:TECH), which offers cutting-edge instruments and bioactive reagents to the research and clinical diagnostic sectors, announced that it has signed a deal to acquire Namocell, Inc. The acquisition is expected to be finalised in the first quarter of Bio-Techne's fiscal 2023.

Bruker:

5. For clients in the biotechnology, pharmaceutical, and life sciences sectors, Bruker Corp. produces diagnostic tests and scientific instruments. Established in 1960. The primary location in the U.S.

Definition:

Spatial omics is an overarching term for different technologies that allow overlaying of -omics data onto tissue images.